George C. Clark, VP, Chief Accounting Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 18,250 shares at $118.05 ($2.1M) on 2022-01-19, disclosed to the SEC on 2022-01-24.
Open-market sale of $2.1M BHVN by VP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $114.93 | 3,196 | $367K | 17.2% |
| 2 | $114.93 | 3,196 | $367K | 17.2% |
| 3 | $116.02 | 2,159 | $250K | 11.7% |
| 4 | $116.02 | 2,159 | $250K | 11.7% |
| 5 | $118.05 | 500 | $59K | 2.8% |
| 6 | $119.37 | 3,520 |
| $420K |
| 19.7% |
| 7 | $119.37 | 3,520 | $420K | 19.7% |
| Total | $116.99 avg | 18,250 | $2.1M | 100% |
| Filing → |
| BHVN | SELL | 2021-12-22 | $474K | — | Filing → |